Henrietta Lacks’s Family Settles Suit With Novartis Over Use of Her Cells

Henrietta Lacks's family reached a settlement with pharmaceutical giant Novartis in recent legal proceedings over the unauthorized use of Henrietta's cells taken without her consent in 1951 while she was battling cervical cancer, with the family accusing the company of profiting from these biological materials. The lawsuit, which highlighted the ethical issues surrounding medical consent and commercialization of human biological materials, centered on the HeLa cells derived from Henrietta Lacks's tumor. These cells became one of the most important tools in medical research, contributing to numerous scientific breakthroughs including the development of the polio vaccine and cancer research. Novartis, which owns hundreds of patents developed through the use of HeLa cells, had previously acknowledged on its website 'the story of Henrietta Lacks, whose cervical cancer cells were surreptitiously commercialized for research purposes without her knowledge.' The settlement represents a significant moment in the ongoing conversation about bioethics, medical consent, and the rights of individuals whose biological materials are used in research.